Losartan Potassium
- Product NDC
- 16571-500
- 11-digit product format
- 165710500
- Labeler code
- 16571
- Product ID
- 16571-500_a1c2686b-bbf3-4afc-aeb5-84a2f64341e3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- losartan potassium
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Rising Pharmaceuticals, Inc
- Application
- ANDA091497
- Marketing category
- ANDA
- Marketing start
- 2011-06-01
- Marketing end
- 0000-00-00
- Substance
- LOSARTAN POTASSIUM
- Active strength
- 25 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 16571-500-11 | 2024-03-01 | C162847 | 48780-1 | 9d75b9d1-29ee-f424-e053-dadaa90a57ce | 3d6a61cd-77c4-4f52-b826-c030df979270 |
| 16571-500-50 | 2024-03-01 | C162847 | 48780-1 | 9d75b9d1-29ee-f424-e053-dadaa90a57ce | 3d6a61cd-77c4-4f52-b826-c030df979270 |
| 16571-500-90 | 2024-03-01 | C162847 | 48780-1 | 9d75b9d1-29ee-f424-e053-dadaa90a57ce | 3d6a61cd-77c4-4f52-b826-c030df979270 |
| 16571-500-11 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-29ee-f424-e053-dadaa90a57ce | 3d6a61cd-77c4-4f52-b826-c030df979270 |
| 16571-500-50 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-29ee-f424-e053-dadaa90a57ce | 3d6a61cd-77c4-4f52-b826-c030df979270 |
| 16571-500-90 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-29ee-f424-e053-dadaa90a57ce | 3d6a61cd-77c4-4f52-b826-c030df979270 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16571-500-50 | EA - Each | 16571-500 | 79fde4e8-03c8-43a5-be4b-a1b7b3dba217 | 1 | 2012-07-24 |